These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1782373)

  • 21. Insulin dependent diabetes mellitus hypothesis of autoimmunity.
    Rossini AA; Handler ES; Greiner DL; Mordes JP
    Autoimmunity; 1991; 8(3):221-35. PubMed ID: 1932509
    [No Abstract]   [Full Text] [Related]  

  • 22. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 23. Type I diabetes: clinical implications of autoimmunity.
    Eisenbarth GS
    Hosp Pract (Off Ed); 1987 Sep; 22(9):167-71, 174, 177 passim.. PubMed ID: 3114287
    [No Abstract]   [Full Text] [Related]  

  • 24. Dendritic cells in the autoimmune insulitis in NOD mouse models of diabetes.
    Rosmalen JG; Leenen PJ; Katz JD; Voerman JS; Drexhage HA
    Adv Exp Med Biol; 1997; 417():291-4. PubMed ID: 9286375
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune diabetes results from genetic defects manifest by antigen presenting cells.
    Serreze DV
    FASEB J; 1993 Aug; 7(11):1092-6. PubMed ID: 8370480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type I diabetes mellitus. A chronic autoimmune disease.
    Eisenbarth GS
    N Engl J Med; 1986 May; 314(21):1360-8. PubMed ID: 3517648
    [No Abstract]   [Full Text] [Related]  

  • 28. Tracking autoimmune T cells in diabetes.
    Serreze DV; Leiter EH
    J Clin Invest; 2003 Sep; 112(6):826-8. PubMed ID: 12975466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes.
    Lo D; Reilly CR; Scott B; Liblau R; McDevitt HO; Burkly LC
    Eur J Immunol; 1993 Jul; 23(7):1693-8. PubMed ID: 7686860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice.
    Shinomiya M; Fazle Akbar SM; Shinomiya H; Onji M
    Clin Exp Immunol; 1999 Jul; 117(1):38-43. PubMed ID: 10403913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation.
    Fox CJ; Danska JS
    Diabetes; 1998 Mar; 47(3):331-8. PubMed ID: 9519736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.
    Ferris ST; Carrero JA; Mohan JF; Calderon B; Murphy KM; Unanue ER
    Immunity; 2014 Oct; 41(4):657-69. PubMed ID: 25367577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets.
    Falcone M; Yeung B; Tucker L; Rodriguez E; Krahl T; Sarvetnick N
    Clin Immunol; 2001 Feb; 98(2):190-9. PubMed ID: 11161975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New insights into insulin dependent diabetes mellitus from studies with transgenic mouse models.
    Grewal IS; Flavell RA
    Lab Invest; 1997 Jan; 76(1):3-10. PubMed ID: 9010445
    [No Abstract]   [Full Text] [Related]  

  • 35. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
    Schmidt D; Verdaguer J; Averill N; Santamaria P
    J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between beta cell injury and antigen presentation in NOD mice.
    Shimizu J; Carrasco-Marin E; Kanagawa O; Unanue ER
    J Immunol; 1995 Oct; 155(8):4095-9. PubMed ID: 7561122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse.
    Yang Y; Bao M; Yoon JW
    Diabetes; 2001 Dec; 50(12):2691-9. PubMed ID: 11723051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune disease. Gadding around the beta cell.
    Cooke A
    Curr Biol; 1994 Feb; 4(2):158-60. PubMed ID: 7953521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.
    Driver JP; Serreze DV; Chen YG
    Semin Immunopathol; 2011 Jan; 33(1):67-87. PubMed ID: 20424843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.